Consolidated statements of income and comprehensive income
(unaudited)
|
Six months ended 30 June |
|
(thousands of €, except share and per share data) |
2017 |
2016 |
Revenues |
60,925 |
38,795 |
Other income |
12,106 |
9,969 |
Total revenues and other income |
73,031 |
48,764 |
|
|
|
Research and development expenditure |
(92,913) |
(62,412) |
General and administrative expenses |
(11,930) |
(9,826) |
Sales and marketing expenses |
(1,090) |
(876) |
Total operating expenses |
(105,933) |
(73,114) |
|
|
|
Operating loss |
(32,903) |
(24,349) |
|
|
|
Fair value re-measurement of share subscription agreement |
– |
57,479 |
Other financial income |
2,319 |
2,081 |
Other financial expenses |
(18,573) |
(3,006) |
|
|
|
Profit / loss (–) before tax |
(49,157) |
32,205 |
|
|
|
Income taxes |
(92) |
24 |
|
|
|
Net income / loss (–) |
(49,249) |
32,229 |
Net income / loss (–) attributable to: |
|
|
Owners of the parent |
(49,249) |
32,229 |
Basic income / loss (–) per share |
(1.03) |
0.71 |
Diluted income / loss (–) per share |
(1.03) |
0.69 |
Weighted average number of shares – basic (in thousands of shares) |
48,043 |
45,229 |
Weighted average number of shares – diluted (in thousands of shares) |
49,987 |
46,756 |
|
Six months ended 30 June |
|
(thousands of €) |
2017 |
2016 |
Net income / loss (–) |
(49,249) |
32,229 |
Items that may be reclassified subsequently to profit or loss: |
|
|
Fair value adjustment of available-for-sale financial assets |
191 |
|
Translation differences, arisen from translating foreign activities |
(316) |
(573) |
Other comprehensive income, net of income tax |
(125) |
(573) |
|
|
|
Total comprehensive income attributable to: |
|
|
Owners of the parent |
(49,374) |
31,656 |